# Validation of the Prostate Cancer Assay - Beta+Pivotal

> **NCT02742259** · — · WITHDRAWN · sponsor: **Celsee Diagnostics**

## Conditions studied

- Metastatic Prostate Cancer, CTC

## Interventions

- **DEVICE:** Blood Draw

## Key facts

- **NCT ID:** NCT02742259
- **Lead sponsor:** Celsee Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2017-04
- **Final completion:** 2017-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrolled participants
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742259, "Validation of the Prostate Cancer Assay - Beta+Pivotal". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02742259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*